Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY-NC-NDJACC. Case reports

Mitral Papillary Muscle Papillary Fibroelastoma in Obstructive Hypertrophic Cardiomyopathy: A Surgically Treated Embolic Source.

4 affiliations
  1. 1Division of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada.
  2. 2Division of Pathology, Toronto General Hospital, Toronto, Ontario, Canada.
  3. 3Division of Cardiovascular Surgery, Toronto General Hospital, Toronto, Ontario, Canada.
  4. 4Division of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada. Electronic address: [email protected].

Abstract

Background

Papillary fibroelastoma, an uncommon cardiac tumor, can cause systemic embolization and raise unique diagnostic and therapeutic challenges when superimposed on a hypertrophic cardiomyopathy.Case summary

A 71-year-old woman with obstructive HCM, prior unilateral retinal artery occlusion (RAO), and progressive exertional dyspnea was referred for Mavacamten therapy. An incidental mitral chordal mass was found on baseline transthoracic echocardiography, suspicious for papillary fibroelastoma. Given the prior unilateral RAO and symptomatic LVOT obstruction, septal myectomy and mass excision were performed. Histopathology confirmed papillary fibroelastoma, and her symptoms and LVOT gradients improved significantly.Discussion

This case underscores the importance of comprehensive imaging to identify rare valvular tumors as potential embolic sources in patients with obstructive HCM and prior embolic events, with important management implications.Take-home message

Mitral papillary fibroelastoma in obstructive HCM, even if "incidental," can be a surgically correctable embolic source beyond atrial fibrillation and may warrant combined resection and myectomy.

Related

  1. Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
    Smita Scholtz, Felix Langkamp, Volker Rudolph +2
    Journal of cardiology casesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.
    Aoife Casey, John McCormick, David Keane
    HeartRhythm case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea
    Stuti Shah, Mohammed Abusafia, Hesham Sheashaa +5
    JACC: AdvancesPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyPMC
  5. Life-long management of atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy following alcohol septal ablation: A10-year follow-up case report
    Keitaro Akita, Yoshihisa Naruse, Makoto Sano +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textCardiovascular medicineJ-STAGE
BibTeX
@article{rashidi2026mitral,
  title = {{Mitral Papillary Muscle Papillary Fibroelastoma in Obstructive Hypertrophic Cardiomyopathy: A Surgically Treated Embolic Source.}},
  author = {Negin Rashidi and Mahdi Montazeri and Cathy Cao and Michael Seidman and Anthony Ralph-Edwards and Harry Rakowski},
  journal = {JACC. Case reports},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jaccas.2026.110553},
  url = {https://europepmc.org/article/MED/42847571},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Mitral Papillary Muscle Papillary Fibroelastoma in Obstructive Hypertrophic Cardiomyopathy: A Surgically Treated Embolic Source.
AU  - Negin Rashidi
AU  - Mahdi Montazeri
AU  - Cathy Cao
AU  - Michael Seidman
AU  - Anthony Ralph-Edwards
AU  - Harry Rakowski
PY  - 2026
DA  - 2026/10/01
JO  - JACC. Case reports
DO  - 10.1016/j.jaccas.2026.110553
UR  - https://europepmc.org/article/MED/42847571
AB  - Background  Papillary fibroelastoma, an uncommon cardiac tumor, can cause systemic embolization and raise unique diagnostic and therapeutic challenges when superimposed on a hypertrophic cardiomyopathy.Case summary  A 71-year-old woman with obstructive HCM, prior unilateral retinal artery occlusion (RAO), and progressive exertional dyspnea was referred for Mavacamten therapy. An incidental mitral chordal mass was found on baseline transthoracic echocardiography, suspicious for papillary fibroelastoma. Given the prior unilateral RAO and symptomatic LVOT obstruction, septal myectomy and mass excision were performed. Histopathology confirmed papillary fibroelastoma, and her symptoms and LVOT gradients improved significantly.Discussion  This case underscores the importance of comprehensive imaging to identify rare valvular tumors as potential embolic sources in patients with obstructive HCM and prior embolic events, with important management implications.Take-home message  Mitral papillary fibroelastoma in obstructive HCM, even if "incidental," can be a surgically correctable embolic source beyond atrial fibrillation and may warrant combined resection and myectomy.
SN  - 2666-0849
ER  -